{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T13:11:08Z","timestamp":1791033068903,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":4546,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1038\/labinvest.2010.75","type":"journal-article","created":{"date-parts":[[2010,4,5]],"date-time":"2010-04-05T10:33:36Z","timestamp":1270463616000},"page":"1169-1178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":115,"title":["Blockade of interleukin-6 signaling enhances hepatic steatosis but improves liver injury in methionine choline-deficient diet-fed mice"],"prefix":"10.1016","volume":"90","author":[{"given":"Kanji","family":"Yamaguchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihiro","family":"Yokomizo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihisa","family":"Niimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Okanoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshikazu","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/labinvest.2010.75_bib1","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experience with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clin Proc"},{"key":"10.1038\/labinvest.2010.75_bib2","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0016-5085(98)70599-2","article-title":"Steatohepatitis: a tale of two \u2018hit\u2019?","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1038\/labinvest.2010.75_bib3","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s11695-007-9187-y","article-title":"Gene expression patterns in hepatic tissue and visceral adipose tissue of patients with non-alcoholic fatty liver disease","volume":"17","author":"Baranova","year":"2007","journal-title":"Obes Surg"},{"key":"10.1038\/labinvest.2010.75_bib4","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2036.2007.03586.x","article-title":"Adipokines and cytokines in non-alcoholic fatty liver disease","volume":"27","author":"Jarrar","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1038\/labinvest.2010.75_bib5","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.cld.2004.04.012","article-title":"Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver disease","volume":"8","author":"Diehl","year":"2004","journal-title":"Clin Liver Dis"},{"key":"10.1038\/labinvest.2010.75_bib6","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1126\/science.274.5291.1379","article-title":"Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice","volume":"274","author":"Cressman","year":"1996","journal-title":"Science"},{"key":"10.1038\/labinvest.2010.75_bib7","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1053\/gast.2003.50098","article-title":"ICAM-1 triggers liver regeneration through TNF and IL-6 release in mice","volume":"124","author":"Selzner","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1038\/labinvest.2010.75_bib8","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1111\/j.1572-0241.2006.00724.x","article-title":"The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, type 2 diabetes, and NASH","volume":"101","author":"Anty","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1038\/labinvest.2010.75_bib9","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/j.1572-0241.2007.01774.x","article-title":"Increased hepatic and circulating interleukin-6 levels in human nonalcoholic steatohepatitis","volume":"103","author":"Wieckowska","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1038\/labinvest.2010.75_bib10","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1172\/JCI30453","article-title":"Gp130 receptor ligands as potential therapeutic targets for obesity","volume":"117","author":"Febbraio","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1038\/labinvest.2010.75_bib11","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nm980","article-title":"Role of STAT-3 in regulation of hepatic gluconeogenic genes and carbohydrate metabolism in vivo","volume":"10","author":"Inoue","year":"2004","journal-title":"Nat Med"},{"key":"10.1038\/labinvest.2010.75_bib12","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1053\/gast.2000.20236","article-title":"Combined interleukin 6 and soluble interleukin 6 receptor accelerates murine liver regeneration","volume":"119","author":"Peters","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1038\/labinvest.2010.75_bib13","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1172\/JCI23640","article-title":"The IL-6-gp130-STAT3 pathway in hepatocytes triggers liver protection in T cell-mediated liver injury","volume":"115","author":"Klein","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1038\/labinvest.2010.75_bib14","doi-asserted-by":"crossref","first-page":"26605","DOI":"10.1074\/jbc.M100740200","article-title":"Interleukin-6 protects against Fas-mediated death by establishing a critical level of anti-apoptotic hepatic proteins FLIP, Bcl-2, and Bcl-xl","volume":"276","author":"Kovalovich","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2010.75_bib15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0016-5085(03)00696-6","article-title":"In vitro interleukin-6 treatment prevents mortality associated with fatty liver transplants in rats","volume":"125","author":"Sun","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1038\/labinvest.2010.75_bib16","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.21728","article-title":"Interleukin-6 inhibits oxidative injury and necrosis after extreme liver resection","volume":"46","author":"Jin","year":"2007","journal-title":"Hepatology"},{"key":"10.1038\/labinvest.2010.75_bib17","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1126\/science.8160012","article-title":"The role of interleukin-6 in mucosal IgA antibody responses in vivo","volume":"264","author":"Ramsay","year":"1994","journal-title":"Science"},{"key":"10.1038\/labinvest.2010.75_bib18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0168-8278(03)00147-8","article-title":"Ischemic preconditioning protects the steatotic mouse liver against reperfusion injury: an ATP dependent mechanism","volume":"39","author":"Selzner","year":"2003","journal-title":"J Hepatol"},{"key":"10.1038\/labinvest.2010.75_bib19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"10.1038\/labinvest.2010.75_bib20","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1038\/labinvest.2010.75_bib21","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2165\/00003495-200969050-00007","article-title":"Tocilizumab: a review of its use in the management of rheumatoid arthritis","volume":"69","author":"Oldfield","year":"2009","journal-title":"Drugs"},{"key":"10.1038\/labinvest.2010.75_bib22","doi-asserted-by":"crossref","first-page":"G1035","DOI":"10.1152\/ajpgi.00199.2004","article-title":"Obese and diabetic db\/db mice develop marked liver fibrosis in a model of nonalcoholic steatohepatitis: role of short-form leptin receptors and osteopontin","volume":"287","author":"Sahai","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1038\/labinvest.2010.75_bib23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0165-2478(02)00202-X","article-title":"Characterization of anti-mouse interleukin-6 receptor antibody","volume":"84","author":"Okazaki","year":"2002","journal-title":"Immunol Lett"},{"key":"10.1038\/labinvest.2010.75_bib24","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.2353\/ajpath.2007.061018","article-title":"Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization","volume":"170","author":"Izumi-Nagai","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1038\/labinvest.2010.75_bib25","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/hep.21655","article-title":"Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis","volume":"45","author":"Yamaguchi","year":"2007","journal-title":"Hepatology"},{"key":"10.1038\/labinvest.2010.75_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.0959-9673.2006.00465.x","article-title":"Mouse models in non-alcoholic fatty liver disease and steatohepatitis research","volume":"87","author":"Anstee","year":"2006","journal-title":"Int J Exp Pathol"},{"key":"10.1038\/labinvest.2010.75_bib27","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1053\/j.gastro.2006.10.014","article-title":"Insulin resistance accelerates a dietary rat model of nonalcoholic steatohepatitis","volume":"132","author":"Ota","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1038\/labinvest.2010.75_bib28","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.intimp.2008.07.002","article-title":"Anti-IL-6 receptor antibody increases blood IL-6 level via the blockade of IL-6 clearance, but not via the induction of IL-6 production","volume":"8","author":"Uchiyama","year":"2008","journal-title":"Int Immunopharmacol"},{"key":"10.1038\/labinvest.2010.75_bib29","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1053\/j.gastro.2008.01.016","article-title":"Cell type-dependent pro- and anti-inflammatory role of signal transducer and activator of transcription 3 in alcoholic liver injury","volume":"134","author":"Horiguchi","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1038\/labinvest.2010.75_bib30","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1038\/labinvest.2010.75_bib31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nm0102-75","article-title":"Interleukin-6-deficient mice develop mature-onset obesity","volume":"8","author":"Wallenius","year":"2002","journal-title":"Nat Med"},{"key":"10.1038\/labinvest.2010.75_bib32","doi-asserted-by":"crossref","first-page":"13740","DOI":"10.1074\/jbc.M210689200","article-title":"Suppressor of cytokine signaling-3, a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes","volume":"278","author":"Senn","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2010.75_bib33","doi-asserted-by":"crossref","first-page":"10422","DOI":"10.1073\/pnas.0402511101","article-title":"Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse","volume":"101","author":"Ueki","year":"2004","journal-title":"Proc Natl Acad Sci"},{"key":"10.1038\/labinvest.2010.75_bib34","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/hep.21087","article-title":"Paradoxical effects of short- and long-term interleukin-6 exposure on liver injury and repair","volume":"43","author":"Jin","year":"2006","journal-title":"Hepatology"},{"key":"10.1038\/labinvest.2010.75_bib35","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1007\/s00125-004-1544-y","article-title":"Short-term infusion of interleukin-6 does not induce insulin resistance in vivo or impair insulin signalling in rats","volume":"47","author":"Rotter Sopasakis","year":"2004","journal-title":"Diabetologia"},{"key":"10.1038\/labinvest.2010.75_bib36","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1194\/jlr.M800042-JLR200","article-title":"Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet","volume":"49","author":"Rinella","year":"2008","journal-title":"J Lipid Res"},{"key":"10.1038\/labinvest.2010.75_bib37","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1172\/JCI8814","article-title":"CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis","volume":"105","author":"Leclercq","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1038\/labinvest.2010.75_bib38","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jhep.2007.12.011","article-title":"Hepatic free fatty acids accumulate in experimental steatohepatitis: role of adaptive pathways","volume":"48","author":"Larter","year":"2008","journal-title":"J Hepatol"},{"issue":"Suppl 2","key":"10.1038\/labinvest.2010.75_bib39","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.2337\/db06-S007","article-title":"Interleukin-6 regulation of AMP-activated protein kinase. Potential role in the systemic response to exercise and prevention of the metabolic syndrome","volume":"55","author":"Ruderman","year":"2006","journal-title":"Diabetes"},{"key":"10.1038\/labinvest.2010.75_bib40","doi-asserted-by":"crossref","first-page":"18069","DOI":"10.1074\/jbc.M610101200","article-title":"Energy depletion inhibits phosphatidylinositol 3-kinase\/Akt signaling and induces apoptosis via AMP-activated protein kinase-dependent phosphorylation of IRS-1 at Ser-794","volume":"282","author":"Tzatsos","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1038\/labinvest.2010.75_bib41","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/ard.2008.104844","article-title":"Over-produced IL-6 decreases blood lipid levels via up-regulation of VLDLR","volume":"69","author":"Hashizume","year":"2010","journal-title":"Ann Rheum Dis"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/labinvest201075.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest201075","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722012909?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683722012909?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/labinvest201075.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T19:38:05Z","timestamp":1758397085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683722012909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0023683722012909"],"URL":"https:\/\/doi.org\/10.1038\/labinvest.2010.75","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blockade of interleukin-6 signaling enhances hepatic steatosis but improves liver injury in methionine choline-deficient diet-fed mice","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/labinvest.2010.75","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2010 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}